Jérôme Hadjadj

14.4k total citations
29 papers, 367 citations indexed

About

Jérôme Hadjadj is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Ophthalmology. According to data from OpenAlex, Jérôme Hadjadj has authored 29 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Genetics and 6 papers in Ophthalmology. Recurrent topics in Jérôme Hadjadj's work include Ocular Diseases and Behçet’s Syndrome (6 papers), Sarcoidosis and Beryllium Toxicity Research (5 papers) and Vasculitis and related conditions (5 papers). Jérôme Hadjadj is often cited by papers focused on Ocular Diseases and Behçet’s Syndrome (6 papers), Sarcoidosis and Beryllium Toxicity Research (5 papers) and Vasculitis and related conditions (5 papers). Jérôme Hadjadj collaborates with scholars based in France, Switzerland and Belgium. Jérôme Hadjadj's co-authors include Benjamin Terrier, Bénédicte Neven, Marie‐Louise Frémond, Solen Kernéis, Luc Mouthon, Hélène Péré, David Veyer, Geoffroy Poulet, Valérie Taly and Nicolas Robillard and has published in prestigious journals such as Blood, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Jérôme Hadjadj

24 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jérôme Hadjadj France 11 86 78 64 59 57 29 367
Nilgün Sallakçı Türkiye 12 72 0.8× 125 1.6× 43 0.7× 119 2.0× 116 2.0× 17 437
Jiehao Zhou United States 9 80 0.9× 217 2.8× 22 0.3× 49 0.8× 17 0.3× 14 432
Cüyan Demirkesen Türkiye 12 33 0.4× 20 0.3× 51 0.8× 74 1.3× 129 2.3× 39 494
Poonam Elhence India 10 80 0.9× 20 0.3× 113 1.8× 89 1.5× 54 0.9× 132 463
Andrew Whyte Australia 12 14 0.2× 50 0.6× 42 0.7× 46 0.8× 47 0.8× 24 412
Nicky Dunn Sweden 12 57 0.7× 87 1.1× 40 0.6× 30 0.5× 68 1.2× 16 340
Jianmin Ma China 9 52 0.6× 12 0.2× 43 0.7× 36 0.6× 80 1.4× 54 299
Regina Fillerová Czechia 13 40 0.5× 69 0.9× 86 1.3× 153 2.6× 33 0.6× 24 361
M. Dandurand France 14 50 0.6× 31 0.4× 45 0.7× 126 2.1× 92 1.6× 48 664
Michel D. Kazatchkine France 9 31 0.4× 230 2.9× 43 0.7× 55 0.9× 55 1.0× 10 530

Countries citing papers authored by Jérôme Hadjadj

Since Specialization
Citations

This map shows the geographic impact of Jérôme Hadjadj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jérôme Hadjadj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jérôme Hadjadj more than expected).

Fields of papers citing papers by Jérôme Hadjadj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jérôme Hadjadj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jérôme Hadjadj. The network helps show where Jérôme Hadjadj may publish in the future.

Co-authorship network of co-authors of Jérôme Hadjadj

This figure shows the co-authorship network connecting the top 25 collaborators of Jérôme Hadjadj. A scholar is included among the top collaborators of Jérôme Hadjadj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jérôme Hadjadj. Jérôme Hadjadj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jachiet, Vincent, Thibault Comont, Olivier Kosmider, et al.. (2025). [VEXAS Syndrome].. PubMed. 75(2). 196–200.
2.
Loeliger, Jordan, Jérôme Hadjadj, P. Blanche, et al.. (2025). Symptomatic Occlusive Retinal Vasculitis as an Unusual Presentation of Biopsy-Proven Sarcoidosis: A Case Series. Ocular Immunology and Inflammation. 33(6). 1042–1045.
3.
Lacombe, Valentin, Jérôme Hadjadj, Sophie Georgin‐Lavialle, et al.. (2024). Vacuoles in bone marrow progenitors: VEXAS syndrome and beyond. The Lancet Haematology. 11(2). e160–e167. 12 indexed citations
4.
5.
Hadjadj, Jérôme, et al.. (2024). VEXAS syndrome: An update. Joint Bone Spine. 91(4). 105700–105700. 9 indexed citations
6.
Nguyen, Yann, Jérôme Hadjadj, Pascal Cohen, et al.. (2023). Risk factors for hypogammaglobulinemia and association with relapse and severe infections in ANCA-associated vasculitis: A cohort study. Journal of Autoimmunity. 142. 103130–103130. 3 indexed citations
7.
Flahault, Adrien, David Veyer, Alexandre Karras, et al.. (2023). Impact of rituximab on humoral response to SARS-CoV-2 vaccination in previously vaccinated patients with autoimmune diseases. Clinical Rheumatology. 42(9). 2485–2490. 2 indexed citations
8.
Jachiet, Vincent, Jérôme Hadjadj, Lin‐Pierre Zhao, et al.. (2023). Manifestations dysimmunitaires associées aux syndromes myélodysplasiques et leucémies myélomonocytaires chroniques. Bulletin du Cancer. 110(11). 1147–1155.
9.
Hadjadj, Jérôme, et al.. (2022). De Novo Vogt-Koyanagi-Harada Disease following Covid-19 Vaccine: A Case Report and Literature Overview. Ocular Immunology and Inflammation. 30(5). 1292–1295. 12 indexed citations
10.
Boussier, Jérémy, Nader Yatim, A. Marchal, et al.. (2021). Severe COVID-19 is associated with hyperactivation of the alternative complement pathway. Journal of Allergy and Clinical Immunology. 149(2). 550–556.e2. 25 indexed citations
11.
Hadjadj, Jérôme, Marie‐Louise Frémond, & Bénédicte Neven. (2021). Emerging Place of JAK Inhibitors in the Treatment of Inborn Errors of Immunity. Frontiers in Immunology. 12. 717388–717388. 28 indexed citations
12.
Courties, Alice, Jérémy Boussier, Jérôme Hadjadj, et al.. (2021). Regulation of the acetylcholine/α7nAChR anti-inflammatory pathway in COVID-19 patients. Scientific Reports. 11(1). 11886–11886. 31 indexed citations
13.
Frumholtz, L., Jean‐David Bouaziz, Maxime Battistella, et al.. (2020). Activation endothéliale associée aux ANCA IgA au cours des lésions de lésions acrales pendant l’épidémie de COVID-19. Annales de Dermatologie et de Vénéréologie. 147(12). A110–A110.
14.
Terrier, Benjamin, S. Humbert, Jérôme Razanamahery, et al.. (2020). Risk of scleroderma according to the type of immune checkpoint inhibitors. Autoimmunity Reviews. 19(8). 102596–102596. 45 indexed citations
15.
Veyer, David, Solen Kernéis, Geoffroy Poulet, et al.. (2020). Highly Sensitive Quantification of Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Sheds Light on its Potential Clinical Value. Clinical Infectious Diseases. 73(9). e2890–e2897. 59 indexed citations
16.
Hadjadj, Jérôme, Guillaume Canaud, Tristan Mirault, et al.. (2018). mTOR pathway is activated in endothelial cells from patients with Takayasu arteritis and is modulated by serum immunoglobulin G. Lara D. Veeken. 57(6). 1011–1020. 35 indexed citations
17.
Hadjadj, Jérôme, Aurélien Guffroy, Guillaume Taïeb, et al.. (2018). Progressive Multifocal Leukoencephalopathy in Primary Immunodeficiencies. Journal of Clinical Immunology. 39(1). 55–64. 14 indexed citations
18.
Hadjadj, Jérôme, Wendy Cuccuini, Bénédicte Deau, et al.. (2017). Uterine intravascular lymphoma as a cause of fever of unknown origin. Annals of Hematology. 96(11). 1891–1896. 3 indexed citations
19.
Hadjadj, Jérôme, Agnès Dechartres, S. Ben Salah, et al.. (2017). Relevance of diagnostic investigations in patients with uveitis: Retrospective cohort study on 300 patients. Autoimmunity Reviews. 16(5). 504–511. 37 indexed citations
20.
Hadjadj, Jérôme, et al.. (2015). Atteintes respiratoires au cours du déficit immunitaire commun variable de l’adulte. Revue des Maladies Respiratoires. 32(10). 991–1001. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nilgün Sallakçı Breakdown of academic impact, for papers by Jiehao Zhou Breakdown of academic impact, for papers by Cüyan Demirkesen Breakdown of academic impact, for papers by Poonam Elhence Breakdown of academic impact, for papers by Andrew Whyte Breakdown of academic impact, for papers by Nicky Dunn Breakdown of academic impact, for papers by Jianmin Ma Breakdown of academic impact, for papers by Regina Fillerová Breakdown of academic impact, for papers by M. Dandurand Breakdown of academic impact, for papers by Michel D. Kazatchkine
Rankless by CCL
2026